Literature DB >> 25019960

Crystallinity and morphology effects on a solvent-processed solar cell using a triarylamine-substituted squaraine.

Supravat Karak1, Paul J Homnick, Andrea M Della Pelle, Youngju Bae, Volodimyr V Duzhko, Feng Liu, Thomas P Russell, Paul M Lahti, S Thayumanavan.   

Abstract

2,4-Bis[4'-(N,N-di(4″-hydroxyphenyl)amino)-2',6'-dihydroxyphenyl]squaraine (Sq-TAA-OH, optical bandgap 1.4 eV, HOMO level -5.3 eV by ultraviolet photoelectron spectroscopy) is used as an active layer material in solution processed, bulk-heterojunction organic photovoltaic cells with configuration ITO/PEDOT:PSS/Sq-TAA-OH:PC71BM/LiF/Al. Power conversion efficiencies (PCEs) up to 4.8% are obtained by a well-reproducible procedure using a mixture of good and poor Sq-TAA-OH solubilizing organic solvents, with diiodooctane (DIO) additive to make a bulk heterojunction layer, followed by thermal annealing, to give optimized V(OC) = 0.84-0.86 V, J(SC) = 10 mA cm(-2), and FF = 0.53. X-ray diffraction and scattering studies of pristine, pure Sq-TAA-OH solution-cast films show d-spacing features similar to single-crystal packing and spacing. The DIO additive in a good solvent/poor solvent mixture apparently broadens the size distribution of Sq-TAA-OH crystallites in pristine films, but thermal annealing provides a narrower size distribution. Direct X-ray diffraction and scattering morphological studies of "as-fabricated" active layers show improved Sq-TAA-OH/PC71BM phase separation and formation of crystallites, ∼48 nm in size, under conditions that give the best PCE.

Entities:  

Year:  2014        PMID: 25019960     DOI: 10.1021/am501965d

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  1 in total

1.  Synthesis and Nanoarchitectonics of Novel Squaraine Derivatives for Organic Photovoltaic Devices.

Authors:  Dragana Vuk; Floren Radovanović-Perić; Vilko Mandić; Vilma Lovrinčević; Thomas Rath; Ivana Panžić; Jerome Le-Cunff
Journal:  Nanomaterials (Basel)       Date:  2022-04-04       Impact factor: 5.076

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.